Xtant Medical Holdings, Inc.
General ticker "XTNT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $79.7M (TTM average)
Xtant Medical Holdings, Inc. follows the US Stock Market performance with the rate: 47.3%.
Estimated limits based on current volatility of 3.6%: low 0.66$, high 0.70$
Factors to consider:
- Total employees count: 232 (+7.9%) as of 2024
- US accounted for 90.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Continuing losses and financing needs, Dependence on key suppliers, Litigation risks, Market competition, Regulatory and compliance
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.27$, 0.77$]
- 2025-12-31 to 2026-12-31 estimated range: [0.23$, 0.67$]
Financial Metrics affecting the XTNT estimates:
- Positive: with PPE of -3.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: -14.19 < Investing cash flow per share per price, % of -6.84
- Negative: Operating cash flow per share per price, % of -21.82 <= 0.04
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Positive: Inventory ratio change, % of -3.99 <= -0.76
- Positive: 42.53 < Shareholder equity ratio, % of 45.78 <= 64.17
- Negative: negative Industry operating cash flow (median)
Short-term XTNT quotes
Long-term XTNT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $57.97MM | $91.30MM | $117.27MM |
| Operating Expenses | $64.72MM | $101.46MM | $129.34MM |
| Operating Income | $-6.75MM | $-10.16MM | $-12.07MM |
| Non-Operating Income | $-1.66MM | $9.12MM | $-4.19MM |
| Interest Expense | $1.69MM | $2.94MM | $4.16MM |
| R&D Expense | $0.92MM | $1.34MM | $2.38MM |
| Income(Loss) | $-8.42MM | $-1.04MM | $-16.26MM |
| Taxes | $0.07MM | $-1.70MM | $0.19MM |
| Profit(Loss)* | $-8.48MM | $0.66MM | $-16.45MM |
| Stockholders Equity | $34.17MM | $51.35MM | $42.96MM |
| Inventory | $17.29MM | $36.88MM | $38.63MM |
| Assets | $60.23MM | $92.61MM | $93.84MM |
| Operating Cash Flow | $-5.34MM | $-9.52MM | $-11.90MM |
| Capital expenditure | $1.76MM | $1.46MM | $4.11MM |
| Investing Cash Flow | $-1.56MM | $-24.78MM | $-3.73MM |
| Financing Cash Flow | $9.02MM | $19.69MM | $16.07MM |
| Earnings Per Share** | $-0.09 | $0.01 | $-0.12 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.